Lactoferricin B

Drug Profile

Lactoferricin B

Latest Information Update: 21 Feb 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Morinaga Milk Industry Company
  • Class Anti-infectives; Iron binding proteins
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bacterial infections; Mycoses; Toxoplasmosis

Most Recent Events

  • 21 Feb 2002 No-Development-Reported for Mycoses in Japan (Unknown route)
  • 13 Nov 2001 No-Development-Reported for Bacterial infections in Japan (Unknown route)
  • 13 Nov 2001 No-Development-Reported for Toxoplasmosis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top